Catherine Novack
Stock Analyst at JonesTrading
(4.61)
# 893
Out of 4,478 analysts
137
Total ratings
42.6%
Success rate
23.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics | Maintained: Buy | $11 → $10 | $1.81 | +452.49% | 4 | Jun 26, 2026 | |
| SPRB Spruce Biosciences | Initiated Coverage: Buy | $135 | $52.51 | +157.09% | 1 | Jun 8, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $6 | $4.91 | +22.20% | 8 | Jun 2, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $35 | $6.26 | +459.11% | 14 | May 19, 2026 | |
| IBIO iBio, Inc. | Maintained: Buy | $7 | $1.68 | +316.67% | 2 | May 13, 2026 | |
| CAPR Capricor Therapeutics | Reiterated: Buy | $29 → $51 | $23.21 | +119.73% | 9 | May 13, 2026 | |
| CRNX Crinetics Pharmaceuticals | Reiterated: Buy | $97 | $42.23 | +129.69% | 16 | May 8, 2026 | |
| KRRO Korro Bio | Upgraded: Buy | $23 | $14.00 | +64.29% | 3 | May 8, 2026 | |
| DTIL Precision BioSciences | Initiated Coverage: Buy | $30 | $8.18 | +266.75% | 2 | Apr 16, 2026 | |
| TSX: MDNA Medicenna Therapeutics Corp. | Rated: Hold | n/a | $0.395 | - | 4 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.82 | - | 10 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $13 | $3.26 | +298.77% | 9 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $143 → $209 | $146.76 | +42.41% | 7 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $34.00 | +26.47% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $33 | $5.70 | +478.95% | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $9 | $2.27 | +296.48% | 14 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $23.07 | n/a | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $6 | $4.17 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.09 | n/a | 6 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $0.9654 | n/a | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.91 | n/a | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $60 | $1.70 | n/a | 4 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.34 | n/a | 4 | Nov 15, 2021 |
ProQR Therapeutics
Jun 26, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $1.81
Upside: +452.49%
Spruce Biosciences
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $135
Current: $52.51
Upside: +157.09%
Rezolute
Jun 2, 2026
Reiterated: Buy
Price Target: $6
Current: $4.91
Upside: +22.20%
Wave Life Sciences
May 19, 2026
Reiterated: Buy
Price Target: $35
Current: $6.26
Upside: +459.11%
iBio, Inc.
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $1.68
Upside: +316.67%
Capricor Therapeutics
May 13, 2026
Reiterated: Buy
Price Target: $29 → $51
Current: $23.21
Upside: +119.73%
Crinetics Pharmaceuticals
May 8, 2026
Reiterated: Buy
Price Target: $97
Current: $42.23
Upside: +129.69%
Korro Bio
May 8, 2026
Upgraded: Buy
Price Target: $23
Current: $14.00
Upside: +64.29%
Precision BioSciences
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $8.18
Upside: +266.75%
Medicenna Therapeutics Corp.
Apr 10, 2026
Rated: Hold
Price Target: n/a
Current: $0.395
Upside: -
Apr 10, 2026
Rated: Hold
Price Target: n/a
Current: $15.82
Upside: -
Feb 24, 2026
Maintained: Buy
Price Target: $7 → $13
Current: $3.26
Upside: +298.77%
Feb 24, 2026
Maintained: Buy
Price Target: $143 → $209
Current: $146.76
Upside: +42.41%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $43
Current: $34.00
Upside: +26.47%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $33
Current: $5.70
Upside: +478.95%
Aug 8, 2025
Maintained: Buy
Price Target: $6 → $9
Current: $2.27
Upside: +296.48%
Jun 25, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $23.07
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $10 → $6
Current: $4.17
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $13
Current: $2.09
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $15
Current: $0.9654
Upside: n/a
Oct 31, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.91
Upside: n/a
Jun 3, 2024
Maintained: Buy
Price Target: $160 → $60
Current: $1.70
Upside: n/a
Nov 15, 2021
Downgraded: Hold
Price Target: n/a
Current: $7.34
Upside: n/a